Clinical Trials Browser

OTHER × Craniopharyngioma × Vemurafenib × Clear all

NCT03224767 2025-02-18

Vemurafenib and Cobimetinib in Treating Patients With BRAF V600E Mutation Positive Craniopharyngioma

Phase 2 Active not recruiting

Craniopharyngioma